Dr. med. Raisa S. Pompe
Berufliche Tätigkeiten
Seit 10/2017 – heute
Assistenzärztin in urologischer Weiterbildung im UKE
07/2016 – 07/2017
Post-doctoral research fellowship,
Cancer Prognostics and Health Outcomes Unit
University of Montreal
09/2014 – 10/2017
Assistenzärztin zur urologischen Weiterbildung in der Martini-Klinik am UKE GmbH
Veröffentlichungen
| 1. Pompe, R.S., Leyh-Bannurah, S.R., Preisser, F. et al.: Radical prostatectomy after previous TUR-P: oncological, surgical and functional outcomes; accepted in Urolog. Oncol. 08/2018 | |
| 2. Pompe, R.S., Beyer, B., Haese, A. et al.: Postoperative complications of contemporary open and robot-assisted laparoscopic radical prostatectomy using standardized reporting systems; BJUI 05/2018 | |
| 3. Tilki, D., Preisser, F., Karakiewicz, P.I. et al.: The impact of time to catheter removal on short-, intermediate- and long-term urinary continence after radical prostatectomy, World J Urol 08/2018 | |
| 4. Pompe, R.S., Tilki, D., Preisser, F. et al.: Survival benefit of local vs. no local treatment for metastatic prostate caner - impact of baseline PSA and metastatic substages; Prostate 07/2018 | |
| 5. Pompe, R.S., Gild, P., Karakiewicz, P.I. et al.: Long-term cancer control outcomes in patients with biochemical recurrence and the impact of time from radical prostatectomy to biochemical recurrence, Prostate 06/2018 | |
| 6. Pompe, R.S., Kühn-Thomä, B., Nagaraj, Y. et al.: Validation of the current eligibility criteria for focal therapy in men with localized prostate cancer and the role of MRI, World J Urol 05/2018 | |
| 7. Pompe, R.S., Bandini, M., Preisser, F. et al.: Contemporary approach to predict early biochemical recurrence after radical prostatectomy: update of the Walz nomogram, Prostate Cancer Prostatic Dis 02/2018 | |
| 8. Pompe, R.S., Smith, A., Bandini, M. et al.: Tumor characteristics, treatments and oncological outcomes of prostate cancer in men aged ≤50 years: a population-based study; Prostate Cancer Prostatic Dis 04/2018 | |
| 9. Pompe, R. S., Karakiewicz, P. I., Zaffuto, E. et al.: External Beam Radiotherapy Affects Serum Testosterone in Patients With Localized Prostate Cancer. J Sex Med: 04/2017 | |
| 10. Pompe, R. S., Davis-Bondarenko, H., Zaffuto, E. et al.: Population-based validation of the 2014 ISUP Gleason grade groups in patients treated with radical prostatectomy, brachytherapy, external beam radiation or no local treatment. Prostate, 01/2017 | |
| 11. Pompe, R. S., Karakiewicz, P. I., Tian, Z. et al.: Oncologic and Functional Outcomes after Radical Prostatectomy for High or Very High Risk Prostate Cancer: European Validation of the Current NCCN Guideline. J Urol, 01/2017 | |
| 12. Pompe, R. S., von Bueren, A. O., Mynarek, M. et al.: Intraventricular methotrexate as part of primary therapy for children with infant and/or metastatic medulloblastoma: Feasibility, acute toxicity and evidence for efficacy. Eur J Cancer, 09/2015 |
Editorials | |
Pompe, R. S., Tilki, D.: Complications after salvage radical prostatectomy: vesicourethral anastomosis leaks and possible prevention. Translational Andrology and Urology, 02/2017 | |
Übersichtsarbeiten
| |
| Tilki, D., Pompe, R.S., Bandini, M. et al.: Local treatment for metastatic prostate cancer: A systematic review, Int J Urol 05/2018 | |
